NOVA LEAP HEALTH CORP (NLH.CA) Stock Fundamental Analysis
TSX-V:NLH - TSX Venture Exchange - CA66980G1090 - Common Stock - Currency: CAD
Overall NLH gets a fundamental rating of 4 out of 10. We evaluated NLH against 16 industry peers in the Health Care Providers & Services industry. NLH has an average financial health and profitability rating. NLH does not seem to be growing, but still is valued expensively.
1. Profitability
1.1 Basic Checks
In the past year NLH was profitable.
In the past year NLH had a positive cash flow from operations.
The reported net income has been mixed in the past 5 years: NLH reported negative net income in multiple years.
In the past 5 years NLH always reported a positive cash flow from operatings.
1.2 Ratios
With a decent Return On Assets value of 3.57%, NLH is doing good in the industry, outperforming 75.00% of the companies in the same industry.
NLH's Return On Equity of 4.54% is fine compared to the rest of the industry. NLH outperforms 68.75% of its industry peers.
The Return On Invested Capital of NLH (3.00%) is better than 68.75% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.57% | ||
| ROE | 4.54% | ||
| ROIC | 3% |
ROA(3y)-0.79%
ROA(5y)2.27%
ROE(3y)-0.91%
ROE(5y)3.92%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
NLH has a better Profit Margin (3.13%) than 62.50% of its industry peers.
In the last couple of years the Profit Margin of NLH has declined.
With a decent Operating Margin value of 2.85%, NLH is doing good in the industry, outperforming 62.50% of the companies in the same industry.
NLH's Gross Margin of 38.64% is fine compared to the rest of the industry. NLH outperforms 62.50% of its industry peers.
NLH's Gross Margin has improved in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 2.85% | ||
| PM (TTM) | 3.13% | ||
| GM | 38.64% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y-13.52%
PM growth 5YN/A
GM growth 3Y4.24%
GM growth 5Y2.71%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so NLH is destroying value.
The number of shares outstanding for NLH has been increased compared to 1 year ago.
The number of shares outstanding for NLH has been increased compared to 5 years ago.
Compared to 1 year ago, NLH has a worse debt to assets ratio.
2.2 Solvency
An Altman-Z score of 3.30 indicates that NLH is not in any danger for bankruptcy at the moment.
The Altman-Z score of NLH (3.30) is better than 87.50% of its industry peers.
The Debt to FCF ratio of NLH is 2.82, which is a good value as it means it would take NLH, 2.82 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of NLH (2.82) is better than 87.50% of its industry peers.
NLH has a Debt/Equity ratio of 0.05. This is a healthy value indicating a solid balance between debt and equity.
Looking at the Debt to Equity ratio, with a value of 0.05, NLH belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.05 | ||
| Debt/FCF | 2.82 | ||
| Altman-Z | 3.3 |
ROIC/WACC0.41
WACC7.3%
2.3 Liquidity
A Current Ratio of 0.82 indicates that NLH may have some problems paying its short term obligations.
With a Current ratio value of 0.82, NLH perfoms like the industry average, outperforming 50.00% of the companies in the same industry.
NLH has a Quick Ratio of 0.82. This is a bad value and indicates that NLH is not financially healthy enough and could expect problems in meeting its short term obligations.
The Quick ratio of NLH (0.82) is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.82 | ||
| Quick Ratio | 0.82 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 382.35% over the past year.
The earnings per share for NLH have been decreasing by -11.19% on average. This is quite bad
NLH shows a small growth in Revenue. In the last year, the Revenue has grown by 0.81%.
Measured over the past years, NLH shows a quite strong growth in Revenue. The Revenue has been growing by 8.16% on average per year.
EPS 1Y (TTM)382.35%
EPS 3Y-11.19%
EPS 5YN/A
EPS Q2Q%-116.67%
Revenue 1Y (TTM)0.81%
Revenue growth 3Y6.58%
Revenue growth 5Y8.16%
Sales Q2Q%10.33%
3.2 Future
No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
4. Valuation
4.1 Price/Earnings Ratio
NLH is valuated quite expensively with a Price/Earnings ratio of 28.00.
Compared to the rest of the industry, the Price/Earnings ratio of NLH indicates a somewhat cheap valuation: NLH is cheaper than 75.00% of the companies listed in the same industry.
When comparing the Price/Earnings ratio of NLH to the average of the S&P500 Index (26.29), we can say NLH is valued inline with the index average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 28 | ||
| Fwd PE | N/A |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, NLH is valued a bit cheaper than 68.75% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, NLH is valued a bit cheaper than 75.00% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 15.05 | ||
| EV/EBITDA | 14.36 |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A
5. Dividend
5.1 Amount
No dividends for NLH!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
TSX-V:NLH (5/29/2025, 7:00:00 PM)
0.28
0 (0%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners18.79%
Ins Owner ChangeN/A
Market Cap24.45M
Analysts84.44
Price Target0.61 (117.86%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 28 | ||
| Fwd PE | N/A | ||
| P/S | 0.68 | ||
| P/FCF | 15.05 | ||
| P/OCF | 14.74 | ||
| P/B | 0.98 | ||
| P/tB | 25.95 | ||
| EV/EBITDA | 14.36 |
EPS(TTM)0.01
EY3.57%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.02
FCFY6.64%
OCF(TTM)0.02
OCFY6.78%
SpS0.41
BVpS0.29
TBVpS0.01
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.57% | ||
| ROE | 4.54% | ||
| ROCE | 3.95% | ||
| ROIC | 3% | ||
| ROICexc | 3.23% | ||
| ROICexgc | 269.04% | ||
| OM | 2.85% | ||
| PM (TTM) | 3.13% | ||
| GM | 38.64% | ||
| FCFM | 4.49% |
ROA(3y)-0.79%
ROA(5y)2.27%
ROE(3y)-0.91%
ROE(5y)3.92%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y-13.52%
PM growth 5YN/A
GM growth 3Y4.24%
GM growth 5Y2.71%
F-Score6
Asset Turnover1.14
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.05 | ||
| Debt/FCF | 2.82 | ||
| Debt/EBITDA | 0.62 | ||
| Cap/Depr | N/A | ||
| Cap/Sales | N/A | ||
| Interest Coverage | 6.07 | ||
| Cash Conversion | 87.57% | ||
| Profit Quality | 143.33% | ||
| Current Ratio | 0.82 | ||
| Quick Ratio | 0.82 | ||
| Altman-Z | 3.3 |
F-Score6
WACC7.3%
ROIC/WACC0.41
Cap/Depr(3y)4.23%
Cap/Depr(5y)2.79%
Cap/Sales(3y)0.15%
Cap/Sales(5y)0.1%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)382.35%
EPS 3Y-11.19%
EPS 5YN/A
EPS Q2Q%-116.67%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)0.81%
Revenue growth 3Y6.58%
Revenue growth 5Y8.16%
Sales Q2Q%10.33%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-9.35%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y34.06%
FCF growth 3Y-14.49%
FCF growth 5Y17.9%
OCF growth 1Y27.88%
OCF growth 3Y-13.97%
OCF growth 5Y17.73%